1st Quarter - Report
INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 1002 SAFE DOSES ACT of 2011. All provisions. Potential prescription drug track-and-trace legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK EUGENE KINNEY | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.